Low-dose decitabine priming endows CAR T cells with enhanced and persistent antitumour potential via epigenetic reprogramming - Concepedia

Concepedia

Publication | Open Access

Low-dose decitabine priming endows CAR T cells with enhanced and persistent antitumour potential via epigenetic reprogramming

DOI Full Paper Access

216

Citations

47

References

2021

Year

Yao Wang, Chuan Tong, Hanren Dai, Zhiqiang Wu, Han Xiao, Yelei Guo, Deyun Chen, Jianshu Wei, Dongdong Ti, Zongzhi Liu,

Nature Communications

References

	Year	Citations

Page 1